Laura Casaní's personal page
at the CSIC-ICCC

Laura Casaní
Head of Animal Experimental Unit (UEA) - Researchers
lcasani@csic-iccc.org
93 556 5901/06

Laura Casaní is a researcher at the Cardiovascular Research Center, center created by association of the Spanish National Research Council (CSIC) and the Catalan Institute of Cardiovascular Sciences (ICCC). She is Doctor in Veterinarian Medicine at the Autonomous University of Barcelona, UAB (1992-1997), master in pharmacology and PhD at the UAB. She also developed a pre-doctoral research fellowship at the Institut National de la Recherche Agronomique, Unité de Recherches sur les Herbibores, in France.

Dr. Casaní is the Responsible of the Experimental Animal Facility (UEA) of Catalan Institute of Cardiovascular Sciences (ICCC) from December of 2003. Her principal duties as a Welfare and Health animal responsible is to manage the UEA, supervision of facilities, animals and experimental procedures with animals, the attention and assessment to the users of the UEA and collaboration in studies performed with experimental animals. Also, she is a member of the Animal Experimentation Committee of the CSIC-ICCC, the main goals of this committee are the revision and the approval of experimental procedures with animals which are performed in the UEA and the supervision and the follow up of the proceedings used.

Complete Curriculum

• 2010
  Glucose-Regulated Protein and Platelet Deposition. Effect of Rosuvastatin.
• 2009
  Induction of RISK by HMG-CoA reductase inhibition affords cardioprotection after myocardial infarction.
• 2009
  Short-term myocardial ischemia induces cardiac modified C-reactive protein expression and proinflammatory gene (cyclo-oxygenase-2, monocyte chemoattractant protein-1, and tissue factor) upregulation in peripheral blood mononuclear cells.
• 2008
  Short-term myocardial ischemia induces cardiac mCRP expression and pro-inflammatory gene (Cox-2, MCP-1, and TF) up-regulation in peripheral blood mononuclear cells.
• 2007
  A thromboxane A2/prostaglandin H2 receptor antagonist (S18886) shows high antithrombotic efficacy in an experimental model of stent-induced thrombosis

+ see more publications

• Cardiovascular benefitial effects associated with beer consumption in a human-like model of acute myocardial infarction
  Other research areas
• Fisiopatología de la obesidad y nutrición
  Molecular pathology of atherosclerosis illness
• Mecanismos celulares y moleculares en arteriosclerosis coronaria e isquemia miocárdica. Implicaciones Terapéuticas.
  Molecular pathology of atherosclerosis illness
• Red Terapia Celular
  Cellular restructuring and cellular cardiomyoplasty